FDA 483 - Catalent Indiana, LLC

This document pertains to an FDA Form 483 inspection conducted at Catalent Indiana, LLC, a facility associated with Novo Nordisk. As no specific observations were provided, a detailed summary of inspectional findings or their severity cannot be presented. Generally, such inspections evaluate compliance with pharmaceutical manufacturing regulations.